Quintiles Transitional Holdings Inc. to Post FY2017 Earnings of $4.61 Per Share, William Blair Forecasts (Q)

Quintiles Transitional Holdings Inc. (NYSE:Q) – Investment analysts at William Blair lifted their FY2017 earnings per share estimates for shares of Quintiles Transitional Holdings in a report issued on Friday. William Blair analyst J. Kreger now forecasts that the medical research company will post earnings of $4.61 per share for the year, up from their prior estimate of $4.57. William Blair has a “Outperform” rating and a $93.42 price objective on the stock. William Blair also issued estimates for Quintiles Transitional Holdings’ Q4 2017 earnings at $1.33 EPS, Q2 2018 earnings at $1.27 EPS, Q3 2018 earnings at $1.37 EPS, Q4 2018 earnings at $1.53 EPS, FY2018 earnings at $5.36 EPS, FY2019 earnings at $6.08 EPS and FY2020 earnings at $6.90 EPS.

Q has been the topic of several other reports. Robert W. Baird raised Quintiles Transitional Holdings from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $76.00 to $93.00 in a research report on Friday, July 7th. Barclays PLC reaffirmed an “overweight” rating and set a $98.00 price objective (up from $90.00) on shares of Quintiles Transitional Holdings in a research report on Monday, July 17th. Zacks Investment Research raised Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 price objective on the stock in a research report on Thursday, July 27th. Jefferies Group LLC reaffirmed a “hold” rating and set a $94.00 price objective on shares of Quintiles Transitional Holdings in a research report on Friday, August 4th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $92.00 price objective (up from $87.00) on shares of Quintiles Transitional Holdings in a research report on Friday, August 4th. Eight equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $101.64.

COPYRIGHT VIOLATION WARNING: This report was originally published by Community Financial News and is the property of of Community Financial News. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.com-unik.info/2017/11/01/quintiles-transitional-holdings-inc-to-post-fy2017-earnings-of-4-61-per-share-william-blair-forecasts-q.html.

Shares of Quintiles Transitional Holdings (Q) opened at 108.10 on Monday. The company has a market capitalization of $23.41 billion, a PE ratio of 313.33 and a beta of 0.62. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $108.81. The stock’s 50 day moving average price is $98.22 and its 200-day moving average price is $91.01.

Quintiles Transitional Holdings (NYSE:Q) last posted its quarterly earnings data on Thursday, October 26th. The medical research company reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.14 by $0.05. The firm had revenue of $2.02 billion for the quarter, compared to the consensus estimate of $2.01 billion. Quintiles Transitional Holdings had a net margin of 0.58% and a return on equity of 12.60%. The business’s revenue for the quarter was up 77.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.00 EPS.

In other Quintiles Transitional Holdings news, insider Kevin C. Knightly sold 20,000 shares of the firm’s stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $90.28, for a total value of $1,805,600.00. Following the transaction, the insider now directly owns 46,826 shares of the company’s stock, valued at $4,227,451.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ari Bousbib sold 92,160 shares of the firm’s stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $90.35, for a total value of $8,326,656.00. Following the completion of the transaction, the insider now directly owns 1,082,919 shares in the company, valued at $97,841,731.65. The disclosure for this sale can be found here. Insiders sold 14,208,382 shares of company stock worth $1,362,839,475 over the last three months. Insiders own 6.40% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in shares of Quintiles Transitional Holdings by 2.2% in the second quarter. Vanguard Group Inc. now owns 12,789,723 shares of the medical research company’s stock worth $1,144,680,000 after buying an additional 280,893 shares during the period. KBC Group NV raised its stake in shares of Quintiles Transitional Holdings by 53.3% in the second quarter. KBC Group NV now owns 18,959 shares of the medical research company’s stock worth $1,697,000 after buying an additional 6,591 shares during the period. Key Square Capital Management LLC bought a new position in shares of Quintiles Transitional Holdings in the second quarter worth about $2,738,000. AXA raised its stake in shares of Quintiles Transitional Holdings by 85.4% in the second quarter. AXA now owns 251,830 shares of the medical research company’s stock worth $22,539,000 after buying an additional 115,993 shares during the period. Finally, TIAA CREF Investment Management LLC raised its stake in shares of Quintiles Transitional Holdings by 5.4% in the second quarter. TIAA CREF Investment Management LLC now owns 832,571 shares of the medical research company’s stock worth $74,515,000 after buying an additional 42,733 shares during the period. 93.03% of the stock is currently owned by hedge funds and other institutional investors.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Earnings History and Estimates for Quintiles Transitional Holdings (NYSE:Q)

What are top analysts saying about Quintiles Transitional Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Quintiles Transitional Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit